PEST sequences in the malaria parasite Plasmodium falciparum : a genomic study

Abstract Background Inhibitors of the protease calpain are known to have selectively toxic effects on Plasmodium falciparum . The enzyme has a natural inhibitor calpastatin and in eukaryotes is responsible for turnover of proteins containing short sequences enriched in certain amino acids (PEST sequ...

Full description

Bibliographic Details
Published in:Malaria Journal
Main Authors: Bell Angus, Mitchell David
Format: Article in Journal/Newspaper
Language:English
Published: BMC 2003
Subjects:
Online Access:https://doi.org/10.1186/1475-2875-2-16
https://doaj.org/article/0310e9818a194bb59e75c32cdbad3a07
Description
Summary:Abstract Background Inhibitors of the protease calpain are known to have selectively toxic effects on Plasmodium falciparum . The enzyme has a natural inhibitor calpastatin and in eukaryotes is responsible for turnover of proteins containing short sequences enriched in certain amino acids (PEST sequences). The genome of P. falciparum was searched for this protease, its natural inhibitor and putative substrates. Methods The publicly available P. falciparum genome was found to have too many errors to permit reliable analysis. An earlier annotation of chromosome 2 was instead examined. PEST scores were determined for all annotated proteins. The published genome was searched for calpain and calpastatin homologs. Results Typical PEST sequences were found in 13% of the proteins on chromosome 2, including a surprising number of cell-surface proteins. The annotated calpain gene has a non-biological "intron" that appears to have been created to avoid an unrecognized frameshift. Only the catalytic domain has significant similarity with the vertebrate calpains. No calpastatin homologs were found in the published annotation. Conclusion A calpain gene is present in the genome and many putative substrates of this enzyme have been found. Calpastatin homologs may be found once the re-annotation is completed. Given the selective toxicity of calpain inhibitors, this enzyme may be worth exploring further as a potential drug target.